FebriDx Antimicrobial Resistance (AMR) Screening Test is a novel, rapid, point-of-care test that differentiates between viral versus bacterial acute respiratory infection in 10 minutes. With 99% accuracy, the test has reduced antibiotic prescriptions by 80%, leading to better efficiencies and lower costs.